Nemolizumab Rapidly Improves Itch and Sleep in Atopic Dermatitis and Prurigo Nodularis: Study
A new study published in the Journal of the European Academy of Dermatology and Venerology showed that nemolizumab, an interleukin-31 pathway inhibitor, offers individuals with moderate-to-severe atopic dermatitis (AD) and…